CNMD CONMED Corporation
Healthcare$36.06-3.14%ClosedMarket Cap: $1.09B
As of 2026-05-26
Valuation
P/E (TTM)
24.07
PEG
—
P/B
1.12
P/S
0.82
EV/EBITDA
9.21
DCF Value
$169.93
FCF Yield
11.0%
Div Yield
1.1%
Margins & Returns
Gross Margin
53.6%
Operating Margin
11.2%
Net Margin
4.0%
ROE
5.4%
ROA
2.4%
ROIC
5.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $317.0M | 57.9% | $25.4M | $13.8M | $— | — |
| Q4 null | $373.5M | 57.1% | $66.9M | $16.7M | $— | — |
| FY null | $1.37B | 52.8% | $141.1M | $47.1M | $— | $0.60 |
| Q3 null | $338.6M | 46.7% | $19.4M | $2.9M | $— | $0.20 |
| Q2 null | $343.0M | 52.6% | $41.7M | $21.4M | $— | $0.20 |
| Q1 null | $319.4M | 52.6% | $11.5M | $6.0M | $— | $0.20 |
| Q4 null | $345.9M | 57.3% | $52.5M | $33.8M | $— | $0.20 |
| FY null | $1.31B | 56.1% | $200.3M | $132.4M | $— | $0.80 |
| Q3 null | $316.7M | 56.5% | $65.7M | $49.0M | $— | $0.20 |
| Q2 null | $332.1M | 55.3% | $47.1M | $30.0M | $— | $0.20 |
| Q1 null | $312.3M | 55.1% | $35.0M | $19.7M | $— | $0.20 |
| Q4 2023 | $327.0M | 55.7% | $50.2M | $33.1M | $1.05 | $0.20 |